Netflix Analysts See More Upside After Record Sub Gain, Price Hikes as Stock Hits All-Time High
The streaming giant gets the latest round of stock price target hikes as experts opine on advertising and live sports upside: ...
ADP Remains a Powerhouse in an Increasingly Competitive Payroll and HCM Industry
ADP is in a strong financial position. At the end of fiscal 2024, the balance sheet was fairly conservative with debt/EBITDA of only 0.6 times. We expect ADP's annual operating income will comfortably ...
Netflix stock a long-term winner—JPMorgan sees global scale driving valuation
The revised price target of $1,150 is based on approximately 38 times the estimated 2026 GAAP EPS of $30.11, which translates ...
Resilient Model and Share Repurchases Strongly Position SLB for Upside in 2025
Delfi boasts a 95% gross retention ratio, according to management figures from late 2022, which suggests a customer lifetime of roughly 20 years. We think a better-than-median retention ratio relative ...
India rating, ease of investing key to G-Sec entry into large indices
Government bonds will be included in the Bloomberg Emerging Market (EM) Local Currency Government Index on January 31, which ...
Biologicals Is The Future In Thermo Fisher: Buy Rating
Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.